Where does Theravalues Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Theravalues Corporation ranks #43,638 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Theravalues Corporation hold?

Theravalues Corporation holds 6 US utility patents granted between 2016 and 2024, spanning 8 technology areas.

What is Theravalues Corporation's Innovation Score?

Theravalues Corporation has an Innovation Score of 34.3 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Theravalues Corporation focus on?

Theravalues Corporation's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 6 patents, ranking #3,449 of 7,163 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Theravalues Corporation's patent grant rate increasing or decreasing?

Theravalues Corporation's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Theravalues Corporation's patents?

Theravalues Corporation's patents average 12.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Theravalues Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Theravalues Corporation

USPTO PatentsView assignee record - 6 granted patents across 8 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Theravalues ranks #43,638 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 8 technology areas.

#43,638
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.3/100): 12.7
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R43638 · Foreign Corporation #43,638 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #43,638/49,997
PHOTO-FINISH THE University OF…
CPC-NARROW A61K · 8 areas
INNOV-THIN 34.3/100
CLAIMS-RICH 12.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: THE University OF Kitakyushu (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Theravalues’s 34.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (20%) Velocity 10.0 pts (29%) Breadth 10.0 pts (29%) Claim depth 7.6 pts (22%)

Qualcomm Incorporated · highest

85
Theravalues · this assignee

34
3D Lighting… · lowest

7

What this shows Theravalues's Innovation Score is 34.3/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Theravalues?

Each dot is one of Theravalues’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Theravalues’s own 12.7 claims/patent is at or below the 13.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Theravalues vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Theravalues's grants concentrate

Theravalues Corporation is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2016. By volume, Theravalues sits between THE University OF Kitakyushu and Thermographic Measurements Limited.

Theravalues's three-year grant acceleration

Theravalues Corporation shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

THE University OF…

6
THE Viki Group

6
THE Young Enginee…

6
Theracos SUB

6
Thermik Geraetebau

6
Thermo CRS

6
Thermodyn

6
Thermographic Mea…

6
Theravalues ◀

6

What this shows Theravalues holds 6 patents at rank #43,539, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Theravalues

By rank, the assignees closest to #43,539 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Theravalues's primary technology class.

Theravalues's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Theravalues Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	16.7%
2019	1	16.7%
2020	1	16.7%
2023	1	16.7%
2024	2	33.3%

Which technologies does Theravalues Corporation patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C07K - Peptides 2

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 2

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

A23K - Fodder 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C07D - Heterocyclic Compounds 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Theravalues Corporation's patent record in context - here's where to go next.

Theravalues Corporation's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #43,638 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Theravalues Corporation against THE University OF Kitakyushu, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.